Literature DB >> 8719177

A natural vaccine candidate strain against cholera.

Y Q Liu1, G M Qi, S X Wang, Y M Yu, G C Duan, L J Zhang, S Y Gao.   

Abstract

E1 Tor Vibrio cholerae (EVC) strains may be classified into two kinds-epidemigenic (EEVC) strains and non-epidemigenic (NEEVC) strains-based on a phage-biotyping system. A large number of EEVC strains have been screened for toxigenic and putative colonization attributes. One such naturally occurring strains (designated IEM101) has been found which is devoid of genes encoding cholera toxin (CT), accessory cholera enterotoxin (ACE), zonula occludens toxin (ZOT), but possesses RS1 sequences and toxin-coregulated pilus A gene (icpA) although icpA is poorly expressed. It expresses type B pili but does not possess type C pili. It is an E1 Tor Ogawa strain and does not cause fluid accumulation in rabbit ilcal loop tests. Active immunization of rabbits with strain IEM101 elicited good protection against challenge with virulent strains of V. cholerae O1. Oral administration caused no side effects in 15 human volunteers, colonized the gut for four to ten days and elicited good immune responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719177

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  7 in total

1.  Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101.

Authors:  Fenggang Yu; Guoming Qi; Yanqing Liu; Shouyi Gao; Biao Kan
Journal:  Mol Biotechnol       Date:  2005-03       Impact factor: 2.695

2.  An environmental Escherichia albertii strain, DM104, induces protective immunity to Shigella dysenteriae in guinea pig eye model.

Authors:  Fatema Moni Chowdhury; Mohammed Ziaur Rahman; Sirajul Islam Khan; Chowdhury Rafiqul Ahsan; Nils-Kåre Birkeland
Journal:  Curr Microbiol       Date:  2014-01-23       Impact factor: 2.188

3.  A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor.

Authors:  I Chen; T M Finn; L Yanqing; Q Guoming; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.

Authors:  Weili Liang; Shixia Wang; Fenggang Yu; Lijuan Zhang; Guoming Qi; Yanqing Liu; Shouyi Gao; Biao Kan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Genetic diversity of toxigenic and nontoxigenic Vibrio cholerae serogroups O1 and O139 revealed by array-based comparative genomic hybridization.

Authors:  Bo Pang; Meiying Yan; Zhigang Cui; Xiaofen Ye; Baowei Diao; Yonghong Ren; Shouyi Gao; Liang Zhang; Biao Kan
Journal:  J Bacteriol       Date:  2007-04-27       Impact factor: 3.490

6.  In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.

Authors:  E T Ryan; T I Crean; M John; J R Butterton; J D Clements; S B Calderwood
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Sequence polymorphisms of rfbT among the Vibrio cholerae O1 strains in the Ogawa and Inaba serotype shifts.

Authors:  Weili Liang; Luxi Wang; Pu Liang; Xiao Zheng; Haijian Zhou; Jingyun Zhang; Lijuan Zhang; Biao Kan
Journal:  BMC Microbiol       Date:  2013-07-26       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.